BOULDER, Colo., May 7, 2015 /PRNewswire/ -- Array BioPharma
Inc. (Nasdaq: ARRY) today announced that its Chief Executive
Officer, Ron Squarer, will present
at the Bank of America Merrill Lynch Healthcare Conference in
Las Vegas and the UBS Global
Healthcare Conference in New York City. The public is welcome
to participate in the conferences through webcasts on the Array
BioPharma website: investor.arraybiopharma.com.
Event:
|
Bank of America
Merrill Lynch Healthcare Conference
|
Date:
|
Thursday, May 14,
2015
|
Time:
|
12:00 p.m.
PDT
|
Location:
|
Encore at the Wynn,
Las Vegas, NV
|
Event:
|
UBS Global Healthcare
Conference
|
Date:
|
Tuesday, May 19,
2015
|
Time:
|
8:30 a.m.
EDT
|
Location:
|
Sheraton New York
Times Square Hotel, NYC, NY
|
About Array BioPharma
Array BioPharma Inc. is a
biopharmaceutical company focused on the discovery, development and
commercialization of targeted small molecule drugs to treat
patients afflicted with cancer. Six Phase 3 studies are
currently advancing. These programs include three cancer drugs,
binimetinib (MEK162 / wholly-owned), encorafenib (LGX818 /
wholly-owned) and selumetinib (AstraZeneca). For more
information on Array, please go to www.arraybiopharma.com.
CONTACT:
|
Tricia
Haugeto
|
|
Array BioPharma
Inc.
|
|
303-386-1193
|
|
thaugeto@arraybiopharma.com
|
Logo -
http://photos.prnewswire.com/prnh/20121029/LA02195LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-bank-of-america-merrill-lynch-healthcare-conference-and-the-ubs-global-healthcare-conference-300078488.html
SOURCE Array BioPharma Inc.